Huang Y - Search Results

1

CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma.

He A, Yang X, Huang Y, Feng T, Wang Y, Sun Y, Shen Z, Yao Y. He A, et al. Among authors: huang y. J Cell Biochem. 2015 Aug;116(8):1719-29. doi: 10.1002/jcb.25131. J Cell Biochem. 2015. PMID: 25736420

2

Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.

He A, Qi W, Huang Y, Sun Y, Shen Z, Zhao H, Yang Y, Yao Y. He A, et al. Among authors: huang y. Int J Clin Oncol. 2013 Jun;18(3):498-505. doi: 10.1007/s10147-012-0409-5. Epub 2012 Apr 26. Int J Clin Oncol. 2013. PMID: 22534798

3

CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study.

He A, Qi W, Huang Y, Feng T, Chen J, Sun Y, Shen Z, Yao Y. He A, et al. Among authors: huang y. Exp Ther Med. 2012 Sep;4(3):435-441. doi: 10.3892/etm.2012.603. Epub 2012 Jun 8. Exp Ther Med. 2012. PMID: 23181114 Free PMC article.

4

Prognostic value of tissue vascular endothelial growth factor expression in bladder cancer: a meta-analysis.

Huang YJ, Qi WX, He AN, Sun YJ, Shen Z, Yao Y. Huang YJ, et al. Asian Pac J Cancer Prev. 2013;14(2):645-9. doi: 10.7314/apjcp.2013.14.2.645. Asian Pac J Cancer Prev. 2013. PMID: 23621212 Free article.

5

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis.

Qi WX, Huang YJ, Yao Y, Shen Z, Min DL. Qi WX, et al. Among authors: huang yj. PLoS One. 2013 Jun 13;8(6):e65166. doi: 10.1371/journal.pone.0065166. Print 2013. PLoS One. 2013. PMID: 23785409 Free PMC article.

6

The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.

Huang YJ, Qi WX, He AN, Sun YJ, Shen Z, Yao Y. Huang YJ, et al. Jpn J Clin Oncol. 2013 Oct;43(10):988-95. doi: 10.1093/jjco/hyt103. Epub 2013 Jul 25. Jpn J Clin Oncol. 2013. PMID: 23894202

7

Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.

Feng T, Qiao G, Feng L, Qi W, Huang Y, Yao Y, Shen Z. Feng T, et al. Among authors: huang y. Mol Med Rep. 2014 Dec;10(6):2985-92. doi: 10.3892/mmr.2014.2618. Epub 2014 Oct 9. Mol Med Rep. 2014. PMID: 25310700

8

Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study.

Huang YJ, He AN, Sun YJ, Shen Z, Min DL, Yao Y. Huang YJ, et al. Asian Pac J Cancer Prev. 2015;16(6):2391-5. doi: 10.7314/apjcp.2015.16.6.2391. Asian Pac J Cancer Prev. 2015. PMID: 25824770 Free article.

9

The prognostic value of D-dimer levels in metastatic osteosarcoma patients treated with second-line chemotherapy.

Huang Y, Liu B, Sun Y, Zhang J, Yao Y, He A. Huang Y, et al. Oncotarget. 2016 Oct 4;7(40):65568-65576. doi: 10.18632/oncotarget.11571. Oncotarget. 2016. PMID: 27564105 Free PMC article.

10

Prognostic value of inflammation-based scores in patients with osteosarcoma.

Liu B, Huang Y, Sun Y, Zhang J, Yao Y, Shen Z, Xiang D, He A. Liu B, et al. Among authors: huang y. Sci Rep. 2016 Dec 23;6:39862. doi: 10.1038/srep39862. Sci Rep. 2016. PMID: 28008988 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81,960 results

Search Page

Filters